A study examining the utility of inhaled mannitol as an additional therapy during an admission to hospital for an acute pulmonary exacerbation in children with cystic fibrosis

Phase 2

Recruiting

• Conditions: Cystic Fibrosis; Respiratory - Other respiratory disorders / diseases; Human Genetics and Inherited Disorders - Cystic fibrosis

• Registration Number: ACTRN12612001167853
• Lead Sponsor: The Children's Hospital at Westmead

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-11-02
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

admission to hospital with a pulmonary exacerbation as defined by the Fuch’s Criteria and requiring IV antibiotic treatment.
at least 6 years of age
FEV1 at least 40% predicted

Exclusion Criteria

commencement of oral steroids (on admission) or new mucolytic (within 3 months of admission)
oxygen requirement or planned surgery during admission
significant haemoptysis during current exacerbation

Study & Design

• Study Type: Interventional
• Study Design: Not specified